Literature DB >> 25019442

Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Meng Xu-Welliver1, William T C Yuh, Julia R Fielding, Katarzyna J Macura, Zhibin Huang, Ahmet S Ayan, Floor J Backes, Guang Jia, Mariam Moshiri, Jun Zhang, Nina A Mayr.   

Abstract

The focus of this article is radiation therapy for gynecologic cancers, with emphasis on imaging-based treatment planning and delivery. For the various gynecologic cancers, radiation oncologists rely on essential clinical information to triage treatment options, and various imaging studies are performed for treatment planning and radiation therapy delivery. A practical approach is provided to help radiologists tailor their reports for the needs of their radiation oncology and gynecologic oncology colleagues, to optimize multidisciplinary care for patients with gynecologic cancer. Template radiology reports are proposed to address the specific information needs of oncologists at each phase-before, during, and after treatment. Fueled by the rapid progress in engineering and computer sciences during the past 2 decades, remarkable advances have been made in anatomic, functional, and molecular imaging and in radiation treatment planning and delivery in patients with gynecologic cancer. Radiation therapy has evolved from a nontargeted approach to a precisely targeted, highly conformal treatment modality, to further improve treatment outcomes and reduce morbidity. High-quality imaging has become essential for staging of the disease, delineation of tumor extent for treatment planning and delivery, and monitoring therapy response. Anatomic and functional imaging has also been shown to provide prognostic information that allows clinicians to tailor therapy on the basis of personalized patient information. This field is an area of active research, and future clinical trials are warranted to validate preliminary results in the field. ©RSNA, 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25019442      PMCID: PMC4319524          DOI: 10.1148/rg.344130099

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  63 in total

Review 1.  Optimized planning using physical objectives and constraints.

Authors:  T Bortfeld
Journal:  Semin Radiat Oncol       Date:  1999-01       Impact factor: 5.934

2.  Staging of cervical cancer.

Authors:  H E Averette; J H Ford; R C Dudan; R E Girtanner; W J Hoskins; M H Lutz
Journal:  Clin Obstet Gynecol       Date:  1975-09       Impact factor: 2.190

3.  Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer: is radiological staging sufficient for planning conservative treatment?

Authors:  Thomas J Cade; Michael A Quinn; Orla M McNally; Deborah Neesham; Jan Pyman; Andrew Dobrotwir
Journal:  Int J Gynecol Cancer       Date:  2010-10       Impact factor: 3.437

4.  Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.

Authors:  Donald G Mitchell; Bradley Snyder; Fergus Coakley; Caroline Reinhold; Gillian Thomas; Marco Amendola; Lawrence H Schwartz; Paula Woodward; Harpreet Pannu; Hedvig Hricak
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

5.  ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

Authors:  Cary Lynn Siegel; Rochelle F Andreotti; Higinia Rosa Cardenes; Douglas L Brown; David K Gaffney; Neil S Horowitz; Marcia C Javitt; Susanna I Lee; Donald G Mitchell; David H Moore; Gautam G Rao; Henry D Royal; William Small; Mahesh A Varia; Catheryn M Yashar
Journal:  J Am Coll Radiol       Date:  2012-06       Impact factor: 5.532

6.  Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging.

Authors:  K Hatano; Y Sekiya; H Araki; M Sakai; T Togawa; Y Narita; Y Akiyama; S Kimura; H Ito
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

7.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

8.  Magnetic resonance imaging in cervical cancer: a basis for objective classification.

Authors:  E Burghardt; H M Hofmann; F Ebner; J Haas; K Tamussino; E Justich
Journal:  Gynecol Oncol       Date:  1989-04       Impact factor: 5.482

9.  The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix.

Authors:  P J Eifel; M Morris; J T Wharton; M J Oswald
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-04-30       Impact factor: 7.038

10.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Authors:  Patricia J Eifel; Kathryn Winter; Mitchell Morris; Charles Levenback; Perry W Grigsby; Jay Cooper; Marvin Rotman; David Gershenson; David G Mutch
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.